In our cross-sectioned study all subjects had albumin concentrations within the normal range and none had conditions leading to abnormal plasma protein turnover. On the above evidence we believe the correlation between GSA and serum fructosamine is valid. D 8HATNAGAR
Biochemical abnormalities in anorexia nervosa and bulimia
We read with interest the recent study by Mira et al. (Ann Clin Biochem 1987; 24: 29-35 ) which describes the biochemical abnormalities associated with anorexia nervosa and bulimia. These authors commented on the possibility of abnormal vitamin D and parathyroid hormone (PTH) concentrations in their patients. Our observations on calcium-related biochemical indices in similar patients may be of interest to readers.
In a series of 17patients with anorexia nervosa, the median serum concentration of 25-hydroxycholecalciIerol (25-0HD) was 8 nmoUL(range: <5-48 nmol/L): this was significantly lower (P«).(X)2) than the
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corresponding values in healthy control subjects (median: 38; range: 13-59 nmoUL). Serum 25-0HO concentrations were subnormal in 15 (88%) of our patients. Serum 1.25-dihydroxycholecalciferol (1.25-OHD) concentrations were low in only two anorexic patients, and the median serum concentration of this metabolite did not differ significantly from that in control subjects. The median serum PTH and plasma calcium and phosphate concentrations in patients with anorexia nervosa were not significantly different from those in controls.
In contrast, seven patients with bulimia (whose body weight was significantly greater than that of the anorexic patients) had median 25-0HO, 1,25-0HO and PTH concentrations that did not differ significantly from those in controls.
Clearly, therefore, hypovitaminosis 0, without clinically evident osteomalacia, is common in patients with anorexia ncrvosa, at least in the UK where diminished sunlight exposure may exacerbate any dietary deficiency. Serum 25-0HD concentrations were not found to be abnormal in anorexics investigated in the USA. I We would also like to comment on the observation by Mira et al. that 13 out of 90 patients with eating disorders had abnormal serum magnesium levels although the mean serum magnesium concentration did not differ significantly from control values. Recognition of oceasional hypomagnesaemia in these patients is clinically relevant since this abnormality may cause refractory cardiac failure, myopathy, and other electrolyte disturbances."
Mira et al. did not report any raised plasma creatinine concentrations in their patients, whereas we reported levels above the normal range in seven out of 10 anorexic patients when this variable was corrected for body weight;" none of our patients had abnormal plasma creatinine concentrations when the uncorrected values were considered.
Lastly. we would like to comment on the suggestion by Mira et al. that the raised plasma cholesterol concentrations may contribute to an increased risk of cardiovascular disease. In this context, it is relevant that we have reported platelet hyperaggregability and enhanced release of thromboxane A2 (a vasoconstrictor and stimulator of platelet aggregation) in patients with anorexia nervosa." We have also suggested that these altered platelet responses may contribute to the pathogenesis of the reported diminished peripheral and renal perfusion in anorexic patients.
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The author repUes as foUows: We would like to thank Fonseca et al. for their comments and their reports of data which add to the literature on medical complications of disordered eating. We have also recently determined the plasma concentration of 25-0H-cholecalciferol on samples collected during our study reported in your journal. I The concentration of 25-0H-cholecalciferol was determined (on heparinised plasma) using competitive protein binding in 20 patients receiving treatment for anorexia nervosa, 56 patients receiving treatment for bulimia and 12 control subjects. The plasma concentrations are shown in Table 1 . Analysis using a two sample r-test showed the differences between the groups were not significant. One anorexia nervosa patient and one bulimia patient had plasma concen- Another explanation is that all subjects in this study were receiving out-patient treatment and therefore were likely to receive greater sun exposure than women receiving in-patient treatment.
We note the comments of Fonseca 1.'/ al. regarding the plasma creatinine concentrations of subjects in our study. We have reported two cases of renal impairment associated with hypokalaemia in women suffering from bulimia both of whom had plasma creatinine concentrations above the control range.I Correction of plasma creatinine levels for body weight may not be totally appropriate in this group of patients as rapid weight changes may occur without corresponding changes in lean body mass." 4 
